276 related articles for article (PubMed ID: 8370583)
21. [Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001-2005].
de Vigan C; Khoshnood B; Cadio E; Vodovar V; Goffinet F
Gynecol Obstet Fertil; 2008 Feb; 36(2):146-150. PubMed ID: 18249576
[TBL] [Abstract][Full Text] [Related]
22. New estimates of Down syndrome risks at chorionic villus sampling, amniocentesis, and livebirth in women of advanced maternal age from a uniquely defined population.
Halliday JL; Watson LF; Lumley J; Danks DM; Sheffield LJ
Prenat Diagn; 1995 May; 15(5):455-65. PubMed ID: 7644436
[TBL] [Abstract][Full Text] [Related]
23. Down syndrome prevention program in a population with an older maternal age.
Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
[TBL] [Abstract][Full Text] [Related]
24. The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992.
Olsen CL; Cross PK; Gensburg LJ; Hughes JP
Prenat Diagn; 1996 Nov; 16(11):991-1002. PubMed ID: 8953632
[TBL] [Abstract][Full Text] [Related]
25. The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome).
Savva GM; Walker K; Morris JK
Prenat Diagn; 2010 Jan; 30(1):57-64. PubMed ID: 19911411
[TBL] [Abstract][Full Text] [Related]
26. [Impact of maternal age distribution on the expected live birth prevalence of Down's syndrome in the metropolitan France between 1965 and 2008].
Rousseau T; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):284-9. PubMed ID: 20381272
[TBL] [Abstract][Full Text] [Related]
27. [Are there any changes in Down Syndrome prevalence in France following the implementation of the measurement of nuchal translucency and maternal serum screening?].
Goujard J
Gynecol Obstet Fertil; 2004 Jun; 32(6):496-501. PubMed ID: 15217564
[TBL] [Abstract][Full Text] [Related]
28. Ten-year trends in prevalence of Down syndrome in a developing country: impact of the maternal age and prenatal screening.
Kurtovic-Kozaric A; Mehinovic L; Malesevic R; Mesanovic S; Jaros T; Stomornjak-Vukadin M; Mackic-Djurovic M; Ibrulj S; Kurtovic-Basic I; Kozaric M
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():79-83. PubMed ID: 27639605
[TBL] [Abstract][Full Text] [Related]
29. Trends in prenatal diagnosis of Down syndrome and other autosomal trisomies in Scotland 1990 to 1994, with associated cytogenetic and epidemiological findings.
Carothers AD; Boyd E; Lowther G; Ellis PM; Couzin DA; Faed MJ; Robb A
Genet Epidemiol; 1999; 16(2):179-90. PubMed ID: 10030400
[TBL] [Abstract][Full Text] [Related]
30. Recent trends in the prevalence of Down syndrome in north-eastern France.
Stoll C; Alembik Y; Dott B; Roth MP
Ann Genet; 1994; 37(4):179-83. PubMed ID: 7710252
[TBL] [Abstract][Full Text] [Related]
31. Advances in medical technology and creation of disparities: the case of Down syndrome.
Khoshnood B; De Vigan C; Vodovar V; Bréart G; Goffinet F; Blondel B
Am J Public Health; 2006 Dec; 96(12):2139-44. PubMed ID: 17077393
[TBL] [Abstract][Full Text] [Related]
32. Recent trends in the prevalence of Down syndrome in Japan, 1980-1997.
Hoshi N; Hattori R; Hanatani K; Okuyama K; Yamada H; Kishida T; Yamada T; Sagawa T; Sumiyoshi Y; Fujimoto S
Am J Med Genet; 1999 Jun; 84(4):340-5. PubMed ID: 10340648
[TBL] [Abstract][Full Text] [Related]
33. Reliability of statistics on Down's syndrome notifications.
Huang T; Watt HC; Wald NJ; Morris JK; Mutton D; Alberman E
J Med Screen; 1997; 4(2):95-7. PubMed ID: 9275267
[TBL] [Abstract][Full Text] [Related]
34. Impact of prenatal diagnosis on revised livebirth prevalence estimates of Down syndrome in the Lothian region of Scotland, 1978-1992.
Huether CA; Haroldson K; Ellis PM; Ramsay CN
Genet Epidemiol; 1996; 13(4):367-75. PubMed ID: 8894639
[TBL] [Abstract][Full Text] [Related]
35. Changes in yearly birth prevalence rates of children with Down syndrome in the period 1986-2007 in The Netherlands.
de Graaf G; Haveman M; Hochstenbach R; Engelen J; Gerssen-Schoorl K; Poddighe P; Smeets D; van Hove G
J Intellect Disabil Res; 2011 May; 55(5):462-73. PubMed ID: 21375641
[TBL] [Abstract][Full Text] [Related]
36. Prenatal diagnosis and elective termination of Down syndrome in a racially mixed population in Hawaii, 1987-1996.
Forrester MB; Merz RD
Prenat Diagn; 1999 Feb; 19(2):136-41. PubMed ID: 10215071
[TBL] [Abstract][Full Text] [Related]
37. [Trisomy 21 and its prenatal detection in the Canton of Vaud (1980-1996)].
Pescia G; Addor MC
Schweiz Med Wochenschr; 2000 Sep; 130(38):1332-8. PubMed ID: 11064925
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: age-related uptake of prenatal screening and invasive diagnostic testing.
Engels MA; Bhola SL; Twisk JW; Blankenstein MA; van Vugt JM
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():59-63. PubMed ID: 24405726
[TBL] [Abstract][Full Text] [Related]
39. Projection of Down's syndrome births in the United States 1979-2000, and the potential effects of prenatal diagnosis.
Huether CA
Am J Public Health; 1983 Oct; 73(10):1186-9. PubMed ID: 6225344
[TBL] [Abstract][Full Text] [Related]
40. [Variations in the prevalence of Down's syndrome in the French population between 1978 and 2005].
Rousseau T; Amar E; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):290-6. PubMed ID: 20430534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
